Found: 23
Select item for more details and to access through your institution.
In-vitro permeation of the insect repellent N,N-diethyl-m-toluamide (DEET) and the sunscreen oxybenzone.
- Published in:
- Journal of Pharmacy & Pharmacology, 2004, v. 56, n. 5, p. 621
- By:
- Publication type:
- Article
Lack of pharmacokinetic interactions between dapagliflozin and simvastatin, valsartan, warfarin, or digoxin.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 2, p. 163, doi. 10.1007/s12325-011-0098-x
- By:
- Publication type:
- Article
Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 3, p. 281, doi. 10.1002/cpdd.650
- By:
- Publication type:
- Article
A Population Pharmacokinetic Meta‐Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 9, p. 1195, doi. 10.1002/jcph.1875
- By:
- Publication type:
- Article
Informing Development of Bispecific Antibodies Using Physiologically Based Pharmacokinetic‐Pharmacodynamic Models: Current Capabilities and Future Opportunities.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, p. S132, doi. 10.1002/jcph.1706
- By:
- Publication type:
- Article
Informing Development of Bispecific Antibodies Using Physiologically Based Pharmacokinetic‐Pharmacodynamic Models: Current Capabilities and Future Opportunities.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, p. S132, doi. 10.1002/jcph.1706
- By:
- Publication type:
- Article
Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 5, p. 1048, doi. 10.1111/bcp.13179
- By:
- Publication type:
- Article
Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 5, p. 1122, doi. 10.1111/bcp.12425
- By:
- Publication type:
- Article
The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 432, doi. 10.1111/bcp.12056
- By:
- Publication type:
- Article
Simultaneous oral therapeutic and intravenous <sup>14</sup>C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 3, p. 763, doi. 10.1111/j.1365-2125.2012.04391.x
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 1, p. 17, doi. 10.1007/s40262-013-0104-3
- By:
- Publication type:
- Article
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 530, doi. 10.1002/cpt.2986
- By:
- Publication type:
- Article
Reverse Translation: The Art of Cyclical Learning.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 2, p. 152, doi. 10.1002/cpt.952
- By:
- Publication type:
- Article
How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development?
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 2, p. 174, doi. 10.1002/cpt.948
- By:
- Publication type:
- Article
Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 2, p. 196, doi. 10.1002/cpt.897
- By:
- Publication type:
- Article
Crowdsourced Asparagus Urinary Odor Population Kinetics.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 1, p. 34, doi. 10.1002/psp4.12264
- By:
- Publication type:
- Article
Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 8, p. 1818, doi. 10.1111/cts.13312
- By:
- Publication type:
- Article
Model Informed Dosing Regimen and Phase I Results of the Anti‐PD‐1 Antibody Budigalimab (ABBV‐181).
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 1, p. 277, doi. 10.1111/cts.12855
- By:
- Publication type:
- Article
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Exploring the Potential of the SGLT2 Inhibitor Dapaglif lozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 412, doi. 10.2337/dc13-2955
- By:
- Publication type:
- Article
Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2013, v. 36, n. 10, p. 3169, doi. 10.2337/dc13-0387
- By:
- Publication type:
- Article